Valuation : Guided Therapeutics, Inc.

Market Cap 24.13M 20.82M 19.61M 17.87M 33.4M 2.28B 33.65M 232M 90.12M 1.17B 90.63M 88.65M 3.83B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 27.01M 23.3M 21.95M 20M 37.38M 2.55B 37.66M 260M 101M 1.3B 101M 99.21M 4.29B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 week-8.40%
Current month+1.78%
1 month-23.67%
3 months+0.44%
6 months-34.57%
Current year-57.59%
1 week 0.19
Extreme 0.19
0.25
1 month 0.18
Extreme 0.18
0.29
Current year 0.17
Extreme 0.17
0.54
1 year 0.15
Extreme 0.15
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 70 2016-11-30
Director/Board Member 76 2006-04-09
Chairman 67 2013-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
3/10/26 Free

Chairman

110,000 0.1316%
3/10/26 Others

Director

466,991 0.5586%
3/10/26 Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-8.40%-18.07%+52.67% 20.27M
+1.34%-3.97%+24.82%+9.21% 222B
+1.44%-2.53%+3.00%-20.96% 145B
+0.71%+0.39%-20.72%+19.80% 130B
+0.60%+0.42%-54.65%-9.79% 69.68B
+0.09%+0.04%+11.07%+18.91% 52.3B
+0.41%+0.51%-14.70%-13.84% 50.71B
+0.97%-2.38%+20.91%+24.18% 42.28B
+1.57%-0.48%+39.03%+46.68% 39.87B
-0.21%-2.05%-14.80%+45.03% 33.37B
Average +0.69%-1.39%-2.41%+17.19% 78.62B
Weighted average by Cap. +0.97%-2.11%+1.55%+7.09%

Financials

2024 2025
Net sales 7K 6.04K 5.69K 5.18K 9.69K 661K 9.76K 67.35K 26.14K 338K 26.29K 25.71K 1.11M 767K 662K 623K 568K 1.06M 72.45M 1.07M 7.38M 2.86M 37.04M 2.88M 2.82M 122M
Net income -2.42M -2.09M -1.96M -1.79M -3.35M -228M -3.37M -23.25M -9.03M -117M -9.08M -8.88M -383M -3.2M -2.76M -2.6M -2.37M -4.42M -302M -4.46M -30.75M -11.93M -154M -12M -11.74M -507M
Net Debt 1.77M 1.53M 1.44M 1.31M 2.45M 167M 2.47M 17.04M 6.61M 85.53M 6.65M 6.5M 281M 2.88M 2.48M 2.34M 2.13M 3.98M 272M 4.01M 27.67M 10.74M 139M 10.8M 10.56M 456M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-09-02 US$0.2500 +19.05% 30,337
26-09-01 US$0.2100 -6.67% 10,000
26-08-31 US$0.2250 -3.02% 2,300
26-08-28 US$0.2320 -1.28% 1,110
26-08-27 US$0.2350 -6.00% 3,471
  1. Stock Market
  2. Stocks
  3. GTHP Stock